673 related articles for article (PubMed ID: 18410546)
1. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.
Tanda ML; Piantanida E; Lai A; Liparulo L; Sassi L; Bogazzi F; Wiersinga WM; Braverman LE; Martino E; Bartalena L
Clin Endocrinol (Oxf); 2008 Nov; 69(5):812-8. PubMed ID: 18410546
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association.
Bartalena L; Wiersinga WM; Tanda ML; Bogazzi F; Piantanida E; Lai A; Martino E
Clin Endocrinol (Oxf); 2004 Oct; 61(4):494-502. PubMed ID: 15473883
[TBL] [Abstract][Full Text] [Related]
3. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
Diehl LA; Romaldini JH; Graf H; Bartalena L; Martino E; Albino CC; Wiersinga WM
Clin Endocrinol (Oxf); 2006 Oct; 65(4):433-8. PubMed ID: 16984234
[TBL] [Abstract][Full Text] [Related]
4. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
5. [Amiodarone and the thyroid gland].
Bednarek-Tupikowska G; Filus A; Kuliczkowska J; Bugajski J
Postepy Hig Med Dosw (Online); 2004 Apr; 58():216-25. PubMed ID: 15114257
[TBL] [Abstract][Full Text] [Related]
6. Approach to the patient with amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
[TBL] [Abstract][Full Text] [Related]
7. Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter.
Liang YL; Huang SM; Peng SL; Hsiao SH; Hung HC; Ou HY; Wu TJ
Ann Pharmacother; 2009 Jan; 43(1):134-8. PubMed ID: 19109209
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone-induced thyrotoxicosis. A review.
Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone-induced thyroid dysfunction in clinical practice.
Ursella S; Testa A; Mazzone M; Gentiloni Silveri N
Eur Rev Med Pharmacol Sci; 2006; 10(5):269-78. PubMed ID: 17121321
[TBL] [Abstract][Full Text] [Related]
10. [The effects of amiodaron on the thyroid function].
Kucharczyk P; Michałkiewicz D; Kucharczyk A
Pol Merkur Lekarski; 2006 Jul; 21(121):86-9. PubMed ID: 17007301
[TBL] [Abstract][Full Text] [Related]
11. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.
Bogazzi F; Martino E; Dell'Unto E; Brogioni S; Cosci C; Aghini-Lombardi F; Ceccarelli C; Pinchera A; Bartalena L; Braverman LE
J Endocrinol Invest; 2003 Jul; 26(7):635-40. PubMed ID: 14594114
[TBL] [Abstract][Full Text] [Related]
12. [Amiodarone treatment and thyroid disorders].
Łacka K; Fraczek MM
Pol Merkur Lekarski; 2013 Jul; 35(205):5-9. PubMed ID: 23984597
[TBL] [Abstract][Full Text] [Related]
13. [Challenges in the management of amiodarone-induced thyrotoxicosis].
Tauveron I; Batisse-Lignier M; Maqdasy S
Presse Med; 2018 Sep; 47(9):746-756. PubMed ID: 30274916
[TBL] [Abstract][Full Text] [Related]
14. Treatment of amiodarone-associated thyrotoxicosis.
Franklyn JA; Gammage MD
Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):662-6. PubMed ID: 17710087
[TBL] [Abstract][Full Text] [Related]
15. Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy.
Bogazzi F; Bartalena L; Dell'Unto E; Tomisti L; Rossi G; Pepe P; Tanda ML; Grasso L; Macchia E; Aghini-Lombardi F; Pinchera A; Martino E
Clin Endocrinol (Oxf); 2007 Oct; 67(4):533-7. PubMed ID: 17561980
[TBL] [Abstract][Full Text] [Related]
16. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
[TBL] [Abstract][Full Text] [Related]
17. Amiodarone-induced thyroid dysfunction.
Danzi S; Klein I
J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
[TBL] [Abstract][Full Text] [Related]
18. Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations.
Dietlein M; Schicha H
Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):145-51. PubMed ID: 15789273
[TBL] [Abstract][Full Text] [Related]
19. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
[TBL] [Abstract][Full Text] [Related]
20. Amiodarone and thyroid.
Eskes SA; Wiersinga WM
Best Pract Res Clin Endocrinol Metab; 2009 Dec; 23(6):735-51. PubMed ID: 19942150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]